Should cancer patients with incurable disease receive parenteral or enteral nutritional support? (Q53574842)

15 May 2018

title

Should cancer patients with incurable disease receive parenteral or enteral nutritional support? (English)

1 reference

15 May 2018

author name string

Barber MD

1

1 reference

15 May 2018

Fearon KC

2

1 reference

15 May 2018

Delmore G

3

1 reference

15 May 2018

Loprinzi CL

4

1 reference

15 May 2018

publication date

1 February 1998

1 reference

15 May 2018

European Journal of Cancer

published in

1 reference

15 May 2018

volume

34

1 reference

15 May 2018

page(s)

279-285

1 reference

15 May 2018

issue

3

1 reference

15 May 2018

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

Prednisolone as an appetite stimulant in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

Seminars in medicine of the Beth Israel Deaconess Medical Center. Neuroendocrine responses to starvation and weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

Changes in body composition of cancer patients following combined nutritional support

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

Parenteral nutrition in patients receiving cancer chemotherapy. American College of Physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

Home parenteral nutrition in adults: a multicentre survey in Europe in 1993

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

Characterization of a cancer cachectic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

Immune and metabolic effects of arginine in the surgical patient

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

Dietary supplementation with L-arginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910049-1

7 January 2021

10.1016/S0959-8049(97)10049-1

Identifiers

DOI

1 reference

15 May 2018

PubMed ID

9640210

1 reference

15 May 2018